Frankfurt - Delayed Quote EUR

Sirona Biochem Corp. (ZSB.F)

0.0430 +0.0030 (+7.50%)
At close: April 26 at 10:41 AM GMT+2
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
10/31/2023
10/31/2022
10/31/2021
10/31/2020
Total Revenue
36.3500
34.7790
671.9230
268.0220
105.7110
Operating Expense
2,485.7070
2,440.6510
4,209.3260
2,564.8320
4,275.6530
Operating Income
-2,449.3570
-2,405.8720
-3,537.4030
-2,296.8100
-4,169.9420
Net Non Operating Interest Income Expense
-267.8820
-201.6510
-26.9980
-3.3320
-13.1290
Other Income Expense
63.2230
63.3790
12.5510
-11.8740
42.2710
Pretax Income
-2,654.0160
-2,544.1440
-3,551.8500
-2,312.0160
-4,140.8000
Tax Provision
-1.2410
-0.9540
5.9540
-5.6810
-7.0760
Net Income Common Stockholders
-2,652.7750
-2,543.1900
-3,557.8040
-2,306.3350
-4,133.7240
Diluted NI Available to Com Stockholders
-2,652.7750
-2,543.1900
-3,557.8040
-2,306.3350
-4,133.7240
Basic EPS
-0.00
-0.01
-0.01
-0.01
-0.02
Diluted EPS
-0.00
-0.01
-0.01
-0.01
-0.02
Basic Average Shares
252,556.1380
252,101.1230
241,039.3800
229,216.4260
226,027.7440
Diluted Average Shares
252,556.1380
252,101.1230
241,039.3800
229,216.4260
226,027.7440
Rent Expense Supplemental
33.4110
35.2640
35.8310
35.8470
35.3330
Total Expenses
2,485.7070
2,440.6510
4,209.3260
2,564.8320
4,275.6530
Net Income from Continuing & Discontinued Operation
-2,652.7750
-2,543.1900
-3,557.8040
-2,306.3350
-4,133.7240
Normalized Income
-2,649.8324
-2,540.3331
-3,562.5413
-2,286.2854
-4,135.3253
Interest Income
--
--
--
--
40.6670
Interest Expense
267.8820
201.6510
26.9980
3.3320
13.1290
Net Interest Income
-267.8820
-201.6510
-26.9980
-3.3320
-13.1290
EBIT
-2,386.1340
-2,342.4930
-3,524.8520
-2,308.6840
-4,127.6710
EBITDA
-2,376.4190
-2,332.7840
-3,515.7610
-2,299.2250
-4,117.9760
Reconciled Depreciation
9.7150
9.7090
9.0910
9.4590
9.6950
Net Income from Continuing Operation Net Minority Interest
-2,652.7750
-2,543.1900
-3,557.8040
-2,306.3350
-4,133.7240
Total Unusual Items Excluding Goodwill
-2.9440
-2.8580
6.4200
-20.0990
1.6040
Total Unusual Items
-2.9440
-2.8580
6.4200
-20.0990
1.6040
Normalized EBITDA
-2,373.4750
-2,329.9260
-3,522.1810
-2,279.1260
-4,119.5800
Tax Rate for Calcs
0.0000
0.0000
0.0003
0.0000
0.0000
Tax Effect of Unusual Items
-0.0014
-0.0011
1.6827
-0.0494
0.0027
10/31/2020 - 5/16/2011

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BION.SW BB Biotech AG Ord
40.45
-0.25%
 
ARGX.BR argenx SE
349.30
+0.90%
 
XBIT XBiotech Inc.
7.87
-4.14%
 
GLPG.AS Galapagos NV
26.68
+0.45%
 
ASMB Assembly Biosciences, Inc.
12.65
-5.31%
 
NOVO-B.CO Novo Nordisk A/S
886.60
+2.28%